Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Dec;30(12):1142–1146. doi: 10.1136/jcp.30.12.1142

Immune complexes and abnormal liver function in haemophilia.

B A McVerry, J Voke, I Mohammed, K M Dormandy, E J Holborow
PMCID: PMC476697  PMID: 604359

Abstract

Abnormal 125I-Clq-binding activity was found in the sera of 94% of 55 haemophiliacs. Sera from 66% of these patients inhibited macrophage uptake of labelled aggregated human IgG in a competitive radiobioassay. These results suggest that large molecular weight immune complexes are present in these sera. Analysis of the precipitates obtained directly from the sera by addition of 4% polyethylene glycol showed either a mixture of IgG and IgM or IgM alone. There was poor correlation between the radiobioassay results and the Clq-binding activities in the whole group of 55 patients, suggesting a heterogeneous population of complexes. Nevertheless, a significant correlation was found between Clq-binding activities and the radiobioassay results in seven patients with antibodies to factor VIII, suggesting a homogeneous population of complexes. There was poor correlation between the level of immune complexes and the amount of replacement therapy the patient had received in the previous six months. Abnormal liver function tests were found in 55% of the patients studied but there was poor correlation between these abnormal levels and the Clq binding activities and radiobioassay results. Only two patients had clinical evidence of liver disease.

Full text

PDF
1142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  2. BIGGS R., BIDWELL E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Br J Haematol. 1959 Oct;5:379–395. doi: 10.1111/j.1365-2141.1959.tb04049.x. [DOI] [PubMed] [Google Scholar]
  3. Biggs R. Jaundice and antibodies directed against factors 8 and 9 in patients treated for haemophilia or Christmas disease in the United Kingdom. Br J Haematol. 1974 Mar;26(3):313–329. doi: 10.1111/j.1365-2141.1974.tb00476.x. [DOI] [PubMed] [Google Scholar]
  4. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  5. Fox R. A., Dudley F. J., Sherlock S. The serum concentration of the third component of complement beta-1C-beta-1A in liver disease. Gut. 1971 Jul;12(7):574–578. doi: 10.1136/gut.12.7.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Heathcote J., Cameron C. H., Dane D. S. Hepatitis-B antigen in saliva and semen. Lancet. 1974 Jan 19;1(7847):71–73. doi: 10.1016/s0140-6736(74)92289-2. [DOI] [PubMed] [Google Scholar]
  7. KUNKEL H. G., MULLER-EBERHARD H. J., FUDENBERG H. H., TOMASI T. B. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest. 1961 Jan;40:117–129. doi: 10.1172/JCI104224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Levine P. H., McVerry B. A., Segelman A. E., Cranford C. M., Zimbler S. Comprehensive health care clinic for hemophiliacs. Arch Intern Med. 1976 Jul;136(7):792–794. [PubMed] [Google Scholar]
  9. Mannucci P. M., Capitanio A., Del Ninno E., Colombo M., Pareti F., Ruggeri Z. M. Asymptomatic liver disease in haemophiliacs. J Clin Pathol. 1975 Aug;28(8):620–624. doi: 10.1136/jcp.28.8.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mohammed I., Barraclough D., Holborow E. J., Ansell B. M. Effect of penicillamine therapy on circulating immune complexes in rheumatoid arthritis. Ann Rheum Dis. 1975 Oct;35(5):458–462. doi: 10.1136/ard.35.5.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Potter B. J., Elias E., Jones E. A. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med. 1976 Sep;88(3):427–439. [PubMed] [Google Scholar]
  13. Potter B. J., Trueman A. M., Jones E. A. Serum complement in chronic liver disease. Gut. 1973 Jun;14(6):451–456. doi: 10.1136/gut.14.6.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Teisberg P., Gjone E. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system. Clin Exp Immunol. 1973 Aug;14(4):509–514. [PMC free article] [PubMed] [Google Scholar]
  15. Thompson R. A., Carter R., Stokes R. P., Geddes A. M., Goodall J. A. Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol. 1973 Jul;14(3):335–346. [PMC free article] [PubMed] [Google Scholar]
  16. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES